Latest News for Fossal Stock (OTC:FSSLY)

Fossal SAA is engaged in investment of securities and shares.

Fossal SAA

Citigroup analyst Jon Tower maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Neutral and lowers the price target from $312 to $297.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on McDonald's, Lowers Price Target to $297

TD Cowen analyst Tara Bancroft downgrades Fusion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUSN#NASDAQ">FUSN</a>) from Buy to Hold.

Downgrades

FUSN

TD Cowen Downgrades Fusion Pharmaceuticals to Hold

Piper Sandler analyst Brad Milsaps maintains Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) with a Neutral and lowers the price target from $34 to $30.

GNTY

Piper Sandler Maintains Neutral on Guaranty Bancshares, Lowers Price Target to $30

When it comes to nixing a nagging toothache, the fix varies as wildly as the reasons behind the pain. From a simple fluoride treatment that does the trick for some to the whole shebang of antibiotics, fillings, or even a root canal for others, the dental remedy truly depends on its cause.
Now, should you manage to get your dentist on the phone and manage an appointment, the process generally involves the dentist playing detective, probing around your teeth and gums, and perhaps snapping a few x-rays to peek at the hidden goings-on below your gum line.
But what if your dental appointment is days away? Fear not! Here are five do-it-yourself reliefs to tide you over:
<h3 class="wp-block-heading">Over-the-Counter Anesthetic</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15111942/tooth-numbing-cream-1024x576.jpeg" alt="Topical anesthetic gels are easy to use and super effective. Image credit: Dall-E 3" class="wp-image-292154" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15111942/tooth-numbing-cream-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15111942/tooth-numbing-cream-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15111942/tooth-numbing-cream-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15111942/tooth-numbing-cream.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Topical anaesthetic gels are easy to use and super effective. Image credit: Dall-E 3</figcaption></figure>
Quick-fix gels like Orajel, packed with benzocaine, can numb the pain faster than you can say &#8220;ouch.&#8221; Just dab it where it hurts. These gels are straightforward to apply, and your local pharmacist can assist you in picking the best one for your needs.
<h3 class="wp-block-heading">Warm Salt Water Rinse</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112329/warm-water-rinse-1024x576.jpeg" alt="A warm salt water rinse is especially effective if an infection is at the root of the toothache. Image credit: Dall-E 3" class="wp-image-292161" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112329/warm-water-rinse-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112329/warm-water-rinse-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112329/warm-water-rinse-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112329/warm-water-rinse.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">A warm salt water rinse is especially effective if an infection is at the root of the toothache. Image credit: Dall-E 3</figcaption></figure>
An oldie but one that works like a charm — swishing warm salt water around your mouth can soothe your gums and tamp down the pain, especially if an infection is to blame. The salt helps fight the infection and reduces inflammation. Just remember, swallowing this briny brew is a no-go as it can upset your stomach and add to your issues.
<h3 class="wp-block-heading">Clove Oil</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112538/clove-oil-1024x576.jpeg" alt="A small drop of clove oil acts as an effective numbing agent. Image credit: Dall-E 3" class="wp-image-292163" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112538/clove-oil-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112538/clove-oil-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112538/clove-oil-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112538/clove-oil.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">A small drop of clove oil acts as an effective numbing agent. Image credit: Dall-E 3</figcaption></figure>
If you've got clove oil handy, a single drop on the gums can significantly reduce pain thanks to its natural numbing properties. Cloves are dental pain relief veterans but remember, less is more—too much can harm your tender mouth tissues. No clove oil? No problem. Chewing on a whole clove can also offer relief.
<h3 class="wp-block-heading">Cold Compress</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112658/cold-compress-toothache-1024x576.jpeg" alt="Applying a cold ice pack on the cheek over the painful area can help relieve pain. Image credit: Dall-E 3" class="wp-image-292170" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112658/cold-compress-toothache-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112658/cold-compress-toothache-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112658/cold-compress-toothache-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112658/cold-compress-toothache.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Applying an ice pack on the cheek over the painful area can help relieve pain. Image credit: Dall-E 3</figcaption></figure>
Swelling often accompanies oral pain. Pressing a cold pack against your cheek not only dulls the pain but also reduces inflammation. Keep your head elevated to prevent further swelling, adding another layer of relief.
<h3 class="wp-block-heading">Over-the-Counter Pain Relievers</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112923/over-the-counter-pills-1024x576.jpeg" alt="Over the counter pills such as ibuprofen or acetaminophen can reduce swelling. Image credit: Dall-E 3" class="wp-image-292176" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112923/over-the-counter-pills-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112923/over-the-counter-pills-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112923/over-the-counter-pills-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/15112923/over-the-counter-pills.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Ibuprofen or acetaminophen can be your saving grace when it comes to dental pain. These non-steroidal anti-inflammatory drugs reduce swelling and can provide substantial relief from various types of tooth pain. Follow the package directions carefully, and consult your doctor or pharmacist about mixing these with other prescriptions.
Image credit: Dall-E 3

Health Care

General

Dealing With Toothache? 5 Emergency Remedies To Try Before Your Dentist Visit

Argus Research analyst Stephen Biggar upgrades Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) from Hold to Buy and announces $465 price target.

Upgrades

Argus Research Upgrades Goldman Sachs Gr to Buy, Announces $465 Price Target

WIIM

CGEM

Cullinan Therapeutics shares are trading higher. The company announced its plan to expand into autoimmune diseases.

Citigroup analyst Michael Ward maintains Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) with a Neutral and raises the price target from $215 to $226.

Citigroup Maintains Neutral on Travelers Companies, Raises Price Target to $226

Piper Sandler analyst Yasmeen Rahimi maintains Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with a Overweight and raises the price target from $31 to $36.

VRNA

Piper Sandler Maintains Overweight on Verona Pharma, Raises Price Target to $36

Honda Motor Co Ltd&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) plans to&nbsp;<a target="_blank" href="https://global.honda/en/newsroom/news/2024/c240416eng.html?from=RSS%3Ffrom%3Dnewsrelease_area" rel="noreferrer noopener">introduce&nbsp;</a>a total of six Ye Series models in China by 2027.
The models include (yè) P7 (Ye P7) and (yè) S7 (Ye S7), as well as the concept model for the second set of series models, Ye GT CONCEPT.
Honda is currently offering the e:N Series EV models in China, where electrification of automobile products is in progress.
The all-new Ye Series models will wear the new &#8220;H mark&#8221; designed exclusively for Honda&#8217;s next-generation EV models.
The Ye Series models feature driving performance by applying a newly developed dedicated EV platform developed in China and integrating it with Honda&#8217;s electrification technologies.
The Ye P7 and the Ye S7 will be available in two variants, a one-motor rear-wheel drive model and a two-motor four-wheel drive model.
The all-new Ye P7 and Ye S7 models are scheduled to go on sale at the end of 2024 and production models based on the Ye GT CONCEPT are scheduled to go on sale before the end of 2025.
Starting with the introduction of the e:NS1 and e:NP1 models in 2022, Honda plans to introduce 10 Honda-brand EV models in China by 2027.
Price Action: HMC shares are trading lower by 1.42% at $35.35 in premarket on the last check Tuesday.
Image Via Shutterstock

Equities

Honda's Next-Gen EV Lineup: Plans 'Ye' Series Rollout In China

Citigroup analyst Michael Ward maintains Hartford Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) with a Buy and raises the price target from $109 to $113.

Citigroup Maintains Buy on Hartford Finl Servs Gr, Raises Price Target to $113

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie"> by analyst accuracy </a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3>Kronos Worldwide, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>)</h3>
<ul>
<li>Dividend Yield: 6.62%</li>
<li>Barclays analyst Michael Leithead maintained an Underweight rating and increased the price target from $7 to $8 on March 26, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Deutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $12 to $11 on May 22, 2023. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: On March 6, Kronos Worldwide reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>)</h3>
<ul>
<li>Dividend Yield: 3.84%</li>
<li>BMO Capital analyst John McNulty upgraded the stock from Market Perform to Outperform and boosted the price target from $19 to $34 on April 9, 2024. This analyst has an accuracy rate of 65%.</li>
<li>UBS analyst Joshua Spector maintained a Neutral rating and increased the price target from $21 to $28 on April 2, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On March 27, Chemours posted upbeat quarterly results.</li>
</ul>
<h3>Kaiser Aluminum Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kalu#NASDAQ">KALU</a>)</h3>
<ul>
<li>Dividend Yield: 3.47%</li>
<li>UBS analyst Curt Woodworth initiated coverage on the stock with a Neutral rating and a price target of $67 on Jan. 16, 2024. This analyst has an accuracy rate of 72%.</li>
<li>Benchmark analyst Josh Sullivan reiterated a Buy rating with a price target of $84 on June 15, 2023. This analyst has an accuracy rate of 81%.</li>
<li>Recent News: Kaiser Aluminum is expected to release its first quarter 2024 financial and operating results on April 24, 2024, after the closing bell.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38244013/over-1m-bet-on-this-consumer-cyclical-stock-check-out-these-3-stocks-insiders-are-buying"> Over $1M Bet On This Consumer Cyclical Stock? Check Out These 3 Stocks Insiders Are Buying</a>
&nbsp;

Dividends

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

KALU

Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields

Intel Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) is looking to launch two&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/04/38221529/whats-going-on-with-key-ai-stocks-amd-intel-nvidia-on-friday" rel="noreferrer noopener">artificial intelligence chips</a>&nbsp;with diminished capabilities so that China can comply with U.S. semiconductor sanctions.
Intel&#8217;s two chips, HL-328 and HL-388, will likely launch in June and September.
Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is also eyeing three China-specific chips after the U.S. tightened its semiconductor embargo on China by including advanced AI chips, Reuters reports.
Intel&#8217;s China-specific AI chips are based on the company&#8217;s latest Gaudi 3 product line. They have similar hardware features, including on-chip memory, high-bandwidth memory, and interface standards.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/03/37630752/intel-and-amd-clash-over-huawei-chip-sales-highlighting-us-sanctions-and-market-dynamics" rel="noreferrer noopener">Intel and AMD Clash Over Huawei Chip Sales, Highlighting US Sanctions and Market Dynamics</a>
However, the company will significantly reduce the chips&#8217; performance to comply with the export control regulations.
One of Nvidia&#8217;s China-specific chips, the H20, will likely be delivered in small batches in the first quarter of 2024, with larger quantities expected in the second quarter.
Recent reports indicated&nbsp;Advanced Micro Devices, Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Intel are encountering obstacles in China following the country&#8217;s decision to respond to U.S. semiconductor sanctions by removing foreign technology from its telecommunications networks.&nbsp;
Chinese authorities have instructed significant telecom operators to eliminate foreign processors by 2027, directly affecting U.S. semiconductor leaders Intel and AMD.&nbsp;
Intel stock gained 13% in the last 12 months. Investors can gain exposure to the stock via&nbsp;First Trust Nasdaq Semiconductor ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXL#NASDAQ">FTXL</a>) and&nbsp;Invesco PHLX Semiconductor ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXQ#NASDAQ">SOXQ</a>).
Price Action:&nbsp;INTC shares traded higher by 0.39% at $36.45 premarket on the last check Tuesday.
Also Read: <a href="https://www.benzinga.com/news/24/01/36596609/nvidia-leads-ai-chip-rivalry-with-new-gpus-while-amd-and-intel-bet-big-on-ai-pcs" target="_blank" rel="noreferrer noopener">Nvidia Leads AI Chip Rivalry with New GPUs, While AMD and Intel Bet Big on AI PCs</a>
Photo via Shutterstock

Government

Regulations

Tech

Media

FTXL

INTC

NVDA

SOXQ

Intel and Nvidia Reveal New Products for China, Adapt AI Chip Strategies in Response to US Sanctions

Citigroup analyst Charlie Lederer maintains Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) with a Neutral and raises the price target from $120 to $126.

CINF

Citigroup Maintains Neutral on Cincinnati Financial, Raises Price Target to $126

BRTX

BioRestorative Therapies Announces FDA Clearance Of Phase 2 BRTX-100 Clinical Study Protocol Amendment

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>American Tower Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amt#NYSE">AMT</a>)</h3>
<ul>
<li>On April 15, Morgan Stanley analyst Simon Flannery maintained American Tower with an Equal-Weight and raised the price target from $183 to $196. The company&rsquo;s stock fell around 6% over the past five days and has a <a href="https://www.benzinga.com/quote/AMT"> 52-week low of $154.58 </a>.</li>
<li>RSI Value: 29.47</li>
<li>AMT Price Action: Shares of American Tower fell 0.6% to close at $178.12 on Monday.</li>
</ul>
<h3>Zillow Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zg#NASDAQ">ZG</a>)</h3>
<ul>
<li>On April 12, JMP Securities analyst Nicholas Jones reiterated Zillow with a Market Outperform and maintained a $68 price target.. The company&rsquo;s stock fell around 9% over the past five days. It <a href="https://www.benzinga.com/quote/ZG"> has a 52-week low </a> of $33.23.</li>
<li>RSI Value: 29.74</li>
<li>ZG Price Action: Shares of Zillow fell 3% to close at $42.41 on Monday.</li>
</ul>
<h3>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>)</h3>
<ul>
<li>On April 12, JMP Securities analyst Nicholas Jones reiterated Opendoor Technologies with a Market Outperform and maintained a $4.5 price target. The company&rsquo;s stock fell around 19% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/OPEN"> low of $1.25.</a></li>
<li>RSI Value: 29.63</li>
<li>OPEN Price Action: Shares of Opendoor fell 6.4% to close at $2.19 on Monday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38263545/johnson-johnson-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-"> Johnson &amp; Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts </a>

Long Ideas

Penny Stocks

OPEN

Top 3 Real Estate Stocks That Could Lead To Your Biggest Gains This Quarter

Piper Sandler analyst Peter Keith maintains Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) with a Overweight and raises the price target from $94 to $110.

BOOT

Piper Sandler Maintains Overweight on Boot Barn Holdings, Raises Price Target to $110

CLN-978 clinical development to focus exclusively on autoimmune diseases, pursuing systemic lupus erythematosus as a first indication &nbsp;
Clinical observations from CLN-978 B-NHL study show rapid, deep, and sustained B cell depletion and clinical activity
Corporate name change to Cullinan Therapeutics reflects strategic expansion into autoimmune diseases
Cullinan Therapeutics to host a virtual investor event taking place on April 16 at 8:00 am ET

Biotech

Cullinan Therapeutics To Pursue Development Of CLN-978 In Autoimmune Diseases, With Systemic Lupus Erythematosus As First Indication; Discontinued Enrollment In Its B-NHL Study To Focus Ongoing Development On Autoimmune Indications

Mizuho analyst Nitin Kumar maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Neutral and raises the price target from $39 to $40.

Mizuho Maintains Neutral on EQT, Raises Price Target to $40

Citigroup analyst Michael Ward maintains Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) with a Buy and raises the price target from $89 to $94.

Citigroup Maintains Buy on Brown & Brown, Raises Price Target to $94

Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) with a Buy and maintains $25 price target.

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

Latest News for Fossal Stock (OTC:FSSLY)